TCL Archive Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent January 27, 2012
TCL Archive Investigators Testing Ways To Overcome Gleevec Resistance: High Dose, New Drugs January 28, 2005
TCL Archive In Brief: LENORA JOHNSON Was Named Director Of Health Education, Communications, And Science Policy at the National Heart Lung and Blood Institute December 17, 2013
